Bio
Prof. Norbert Kraut is a renowned international expert in cancer research, serving as a Senior Executive Scientist at Boehringer Ingelheim, as a member of the Discovery Research Leadership Committee and working across multiple functions within the Boehringer Ingelheim Innovation Unit. With a career spanning over two decades dedicated to oncology, Norbert Kraut has been instrumental in driving forward the discovery of novel cancer treatments at Boehringer. His tenure in the company was marked by his previous role as the Global Head of Cancer Research for over ten years, where he led an international team to pursue innovative therapies for hard-to-treat cancers.
An accomplished academic, Norbert Kraut completed his PhD in Molecular Biology at the European Molecular Biology Laboratory (EMBL) in Heidelberg, followed by a postdoctoral fellowship at the Fred Hutchinson Cancer Research Center in Seattle. He has an appointment at the University of Ulm in Physiological Chemistry, where he continues to share his expertise as an adjunct professor. Norbert is member of several boards, including the Institute of Molecular Pathology (IMP) in Vienna, the MD Anderson Cancer Center and the AACR Lung Cancer Task Force. His research focus on pioneering approaches to cancer therapy has resulted in numerous major publications and presentations at international cancer conferences.